1.Granulocyte Colony-Stimulating Factor-Induced Psoriasiform Dermatitis Improved by Narrowband Ultraviolet B.
Min Soo JANG ; Jong Bin PARK ; Joon Hee KIM ; Myeong Hyeon YANG ; Kang Hoon LEE ; Sang Hwa HAN ; Kee Suck SUH
Annals of Dermatology 2017;29(2):232-233
No abstract available.
Dermatitis*
;
Granulocytes*
2.The effect of granulocyte colony stimulating facto(G-CSF) in a patient with propylthiouracil-induced agranulocytosis.
Kwang Hyen YOU ; Seung Si SON ; Seung Yel SONG ; Myoung Seon PARK ; Yong Gu LEE ; Chung Gu CHO
Journal of Korean Society of Endocrinology 1993;8(3):347-350
No abstract available.
Agranulocytosis*
;
Granulocytes*
;
Humans
3.Phase II clinical trial of recombinant human granulocyte colony-stimulating factor(fhG-CSF)(KRN8601) in advanced cancer patients with myelosuppression after chemotherapy.
Jae Kyung ROH ; Jin Hyuk CHOI ; Kyung Hee LEE ; Hye Ran LEE ; Nae Choon YOO ; Joo Hang KIM ; Byung Soo KIM ; Ho Young LIM
Journal of the Korean Cancer Association 1993;25(5):725-735
No abstract available.
Drug Therapy*
;
Granulocytes*
;
Humans*
4.To evaluate the efficacy of transfusion of white blood granulocyte mass for treating severe burn with bacterial infection and intoxication associated with leucopenia
Journal of Practical Medicine 2003;454(6):26-28
83 burn patients with the syndrome of bacterial infection and intoxication associated with leucopenia were divided in to 2 groups, the one of 32 patients without transfusion of white blood granulocyte, the other 51 patients with a transfusion rich with neutrophile leucocyte. Results: In the group of the syndrome of severe bacterial infection and intoxication associated with leucopenia, 39.2% have had complication, less than no transfusion group (68.7%). Mortality of the transfusion group: 82.4%, is higher than no transfusion group: 40.6%
Burns
;
Bacterial Infections
;
Granulocytes
5.Unusual Morphology of Eosinophil Nucleus: Presented with Double Chromatin Filament Bridge: Report of Three Cases.
Ae Seek KIM ; Young Hee KONG ; Ji Youn KIM
Korean Journal of Clinical Pathology 1998;18(2):122-125
We found an unusual morphology of eosinophil nucleus having longer chromatin filament in addition to a single narrow chromatin bridge. The nucleus having two chromatin filament bridge looked like two legged eosinophil, instead of usual glasses shape. As the physiologic function of the nucleus of granulocyte segmentation and the mechanism by which the lobes are formed during differention is still unknown, we could not know the definite nature and significance of these double chromatin filament. However we could suggest that they may be a reactive change of eosinophilia. This not uncommon morphology has not been described as yet. Here we report three cases of unusual morphology of eosinophil nucleus presenting double chromatin filament bridge, one case with a band form nucleus looked like ring shape, with brief review of literatures.
Chromatin*
;
Eosinophilia
;
Eosinophils*
;
Eyeglasses
;
Glass
;
Granulocytes
;
Leg
6.Efficacy of recombinant human granulocyte colony-stimulating factor(neutrogin) for chemotherapy induced neutropenia in patients with advanced lung carcinoma.
Nae Choon YOO ; Joo Hang KIM ; Yi Young LEE ; Se Kyoo KIM ; Sung Kyoo KIM ; Won Young LEE ; Bong Soo CHA ; Jin Hyuk CHOI ; Ho Young LIM ; Jae Kyung ROH ; Byung Soo KIM
Journal of the Korean Cancer Association 1993;25(2):236-246
No abstract available.
Drug Therapy*
;
Granulocytes*
;
Humans*
;
Lung*
;
Neutropenia*
7.Two cases of congenital agranulocytosis treated with recombinant human granulocyte colony-stimulating factor.
Byoung Ho CHA ; Seung Hwan OH ; Chukl Joo LYU ; Chang Hyun YANG ; Kir Young KIM
Korean Journal of Hematology 1992;27(2):325-329
No abstract available.
Agranulocytosis*
;
Granulocyte Colony-Stimulating Factor*
;
Granulocytes*
;
Humans*
8.Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.
Aakanksha SINGH ; Sandeep GROVER ; Pankaj MALHOTRA ; Subhash C VARMA
Clinical Psychopharmacology and Neuroscience 2016;14(2):212-217
Agranulocytosis as a side effect of clozapine has been reported to be associated with initial phases of treatment, i.e., first six months. Agranulocytosis with clozapine during the initial phases of treatment has been linked to genetic vulnerability in the form of variations in the human leukocyte-antigen haplotypes. However, there is limited literature on late onset agranulocytosis with clozapine and this has very rarely been linked to human leukocyte-antigen haplotypes vulnerability. In this report we review the existing data on late onset agranulocytosis with clozapine and describe the case of a young man, who developed agranulocytosis with clozapine after 35 months of treatment and was found to have genetic vulnerability in form of being positive for HLA DR4. This case highlights underlying autoimmune immune mechanism in clozapine-induced agranulocytosis and the need for frequent blood count monitoring on clozapine even after the initial 6 months of starting treatment especially in patients with genetic vulnerability to develop this condition.
Agranulocytosis*
;
Clozapine*
;
Granulocyte Colony-Stimulating Factor*
;
Granulocytes*
;
Haplotypes
;
Humans
;
Neutropenia
9.Evaluation of the ABX Pentra DX 120 for the Detection of Immature Cells in Peripheral Blood.
Young Kyung LEE ; Hee Jung KANG ; Young Min KIM ; Chul Yeon WON ; Hyoun Chan CHO
Journal of Laboratory Medicine and Quality Assurance 2008;30(2):249-258
INTRODUCTION: The ABX Pentra DX 120 (Pentra DX 120, ABX Diagnostics, Montpellier, France) adopted new technologies to perform differential leukocyte and erythroblast counts. The double matrix can discriminate Large Immature Cell (LIC), Immature Granulocyte (IMG), Immature Monocyte (IMM), Immature Lymphocyte (IML), and Atypical lymphocyte (ALY) in addition to a routine 5-differential count. For erythroblast (ERB), a fluorescence method is employed. In this study, we evaluated the performance of the Pentra DX 120 in the performance of differential leukocyte and erythroblast counts. METHODS: Precision was evaluated using 3-level control materials. Comparison analysis was performed on 200 samples: 100 normal and 100 abnormal samples. We evaluated the 5 part differential count, LIC, IMG, IMM, IML, ALY, and ERB. These parameters were analyzed in comparison with the results from the reference method, manual differential count. RESULTS: The coefficients of variation (CVs) of precision were <5% for neutrophils and lymphocytes, <15% for eosinophils and basophils and <7% for erythroblasts. The correlation coefficients (r) were >0.9 except monocytes and basophils. IMG, ALY and erythroblasts were also well correlated with manual count (r=0.8315, 0.5602, 0.8144, respectively). The efficiency of flagging system was 84% for LIC, 80% for ALY, and 78.0% for increased ERB (>2/100WBCs). CONCLUSIONS: The Pentra DX 120 performed reliable differential leukocyte and IMG, ALY, and ERB results demonstrated comparable performance to manual count. And, the flagging system was efficient for detecting each abnormal cell population. We expect the Pentra DX 120 double matrix and erythroblast count can reduce microscopic review rate in routine laboratory and promote laboratory efficiency.
Basophils
;
Eosinophils
;
Erythroblasts
;
Fluorescence
;
Granulocytes
;
Leukocytes
;
Lymphocytes
;
Monocytes
;
Neutrophils
10.Chemopotentiation of Fresh Acute Myelogenous Leukemic Cells by Recombinant Human Granulocyte - Macrophage Colony - Stimulating Factor ( GM-CSF ) and Methotrexate.
Heung Tae KIM ; Jin Seok AHN ; Eun Shil KIM ; Yung Jue BANG ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1998;30(2):357-369
No abstract available.
Granulocyte-Macrophage Colony-Stimulating Factor*
;
Granulocytes*
;
Humans*
;
Macrophages*
;
Methotrexate*